Hematology/Oncology News

Olanzapine significantly reduced nausea and vomiting compared with observation for patients with solid tumors undergoing moderately emetogenic chemotherapy, according to results of a randomized phase 3 trial.

The FDA expanded the approval of durvalumab for lung cancer.

Neoadjuvant immunotherapy may allow more people with hepatocellular carcinoma to undergo surgical resection, according to retrospective study results.

Most cancer care programs offer some survivorship services, but many patients do not use them due to lack of referrals or low awareness of their existence, according to survey results.

Enrollment for a randomized phase 2 trial designed to compare a triplet regimen and doublet regimen for certain patients with leukemia has been discontinued due to low likelihood of benefit.

Spouses of people with cancer exhibited significantly higher risk for attempted suicide and suicide death than those whose spouses had not been diagnosed with cancer, according to a nationwide cohort study in Denmark.

More than half of people with iron deficiency continued to have low iron levels 3 years after diagnosis, according to retrospective study results.

Women surgeons across three surgical subspecialties received lower reimbursement for fee-for-service procedures, submitted less charges and experienced lower practice volume vs. men surgeons, according to study results.

The FDA approved axatilimab-csfr for certain patients with chronic graft-versus-host disease.

The Healio news staff received an APEX award in the category of Writing/Topics for work on the potential role of psychedelics and alternative therapies for mental health issues and other medical conditions.